Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease. uri icon

authors

  • Baksh, Sheriza N
  • Jodi Segal, MD, MPH
  • McAdams-DeMarco, Mara
  • Kalyani, Rita R
  • Alexander, G Caleb
  • Ehrhardt, Stephan

publication date

  • January 1, 2020